Scarica l'app Stockscreener
3.40
1.73%
-0.06
Dopo l'orario di chiusura:
3.40
Precedente Chiudi:
$3.46
Aprire:
$3.45
Volume 24 ore:
58,947
Relative Volume:
0.69
Capitalizzazione di mercato:
$58.78M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-6.34%
1M Prestazione:
+1.19%
6M Prestazione:
-11.23%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$3.25
$3.53
Intervallo di 1 settimana:
$3.25
$3.6458
Portata 52W:
$2.88
$6.00
Mural Oncology Plc Stock (MURA) Company Profile
Nome
Mural Oncology Plc
Settore
Industria
Telefono
353 1 905 8020
Indirizzo
10 EARLSFORT TERRACE, DUBLIN 2
Mural Oncology Plc Borsa (MURA) Ultime notizie
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Mural Oncology CFO Adam Cutler sells $25,305 in company stock By Investing.com - Investing.com Canada
Mural Oncology plc (NASDAQ:MURA) CFO Adam D. Cutler Sells 7,421 Shares - MarketBeat
Mural Oncology CFO Adam Cutler sells $25,305 in company stock - Investing.com
Short Interest in Mural Oncology plc (NASDAQ:MURA) Decreases By 15.7% - MarketBeat
HC Wainwright Comments on Mural Oncology Q3 Earnings - MarketBeat
Mural Oncology (NASDAQ:MURA) Coverage Initiated at HC Wainwright - MarketBeat
HC Wainwright & Co. Initiates Coverage of Mural Oncology (MURA) with Buy Recommendation - MSN
167,644 Shares in Mural Oncology plc (NASDAQ:MURA) Bought by Squarepoint Ops LLC - MarketBeat
232,100 Shares in Mural Oncology plc (NASDAQ:MURA) Bought by Renaissance Technologies LLC - MarketBeat
Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - The Manila Times
Raymond James Begins Coverage on Mural Oncology (NASDAQ:MURA) - Defense World
Mural Oncology (NASDAQ:MURA) Coverage Initiated by Analysts at Raymond James - MarketBeat
Rhumbline Advisers Makes New $34,000 Investment in Mural Oncology plc (NASDAQ:MURA) - Defense World
Point72 Asia Singapore Pte. Ltd. Invests $84,000 in Mural Oncology plc (NASDAQ:MURA) - Defense World
Mural Oncology Highlights Clinical Trials During It's Maiden Investor Day - Forbes
Armistice Capital LLC Takes Position in Mural Oncology plc (NASDAQ:MURA) - Defense World
1,688,000 Shares in Mural Oncology plc (NASDAQ:MURA) Acquired by Armistice Capital LLC - MarketBeat
Mural Oncology's First Virtual Investor Day to Highlight Late-Stage Clinical Progress - The Manila Times
Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress - StockTitan
Mural Oncology appoints new board member amid growth phase - Investing.com
Mural Oncology appoints new director and audit chair - Investing.com
Mural Oncology appoints new director and audit chair By Investing.com - Investing.com UK
Mural Oncology Appoints Sachiyo Minegishi To Board - citybiz
Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi - EIN News
Mural Oncology appoints new board member amid growth phase By Investing.com - Investing.com South Africa
Primecap Management Co. CA Purchases Shares of 235,551 Mural Oncology plc (NASDAQ:MURA) - MarketBeat
Primecap Management Co. CA Buys New Holdings in Mural Oncology plc (NASDAQ:MURA) - Defense World
Acadian Asset Management LLC Takes $998,000 Position in Mural Oncology plc (NASDAQ:MURA) - MarketBeat
Acadian Asset Management LLC Buys Shares of 318,536 Mural Oncology plc (NASDAQ:MURA) - Defense World
Mural Oncology to Host First Virtual Investor Day on September 26, 2024 - ForexTV.com
We Think Mural Oncology (NASDAQ:MURA) Needs To Drive Business Growth Carefully - Yahoo Finance
MURAMural Oncology plc Ordinary Shares Latest Stock News & Market Updates - StockTitan
Mural Oncology to Present at Two Upcoming Investor Conferences - ForexTV.com
Mural Oncology plc (NASDAQ:MURA) Sees Significant Decrease in Short Interest - MarketBeat
Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress - BioSpace
Harbor Capital Advisors Inc. Takes Position in Mural Oncology plc (NASDAQ:MURA) - Defense World
Critical Analysis: Mural Oncology (NASDAQ:MURA) & Kamada (NASDAQ:KMDA) - Defense World
Mural Oncology Appoints George Golumbeski, Ph.D., to its Board of Directors - citybiz
Mural Oncology appoints new independent director By Investing.com - Investing.com Nigeria
Mural Oncology appoints George Golumbeski to board - Investing.com
Mural Oncology appoints new independent director - Investing.com India
Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors - ForexTV.com
Head to Head Survey: Mural Oncology (NASDAQ:MURA) and Mereo BioPharma Group (NASDAQ:MREO) - Defense World
Mural Oncology plc (NASDAQ:MURA) Short Interest Down 18.4% in June - Defense World
Short Interest in Mural Oncology plc (NASDAQ:MURA) Declines By 18.4% - MarketBeat
Evaluating MURA’s financial ratios for a profitable investment - US Post News
Mural Oncology plc (NASDAQ:MURA) CEO Caroline Loew Sells 12,531 Shares of Stock - Defense World
Mural Oncology plc (NASDAQ:MURA) CEO Caroline Loew Sells 12,531 Shares - MarketBeat
Mural Oncology reports inducement grants under Nasdaq listing rule - Medical Buyer
Mural Oncology Plc Azioni (MURA) Dati Finanziari
Non sono disponibili dati finanziari per Mural Oncology Plc (MURA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
5.11%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):